ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0916

Trust in the Usual Nephrologist, Patient Hope, and Shared Decision-Making Quality in Kidney Replacement Therapy Selection: A Multicenter Cross-Sectional Study

Session Information

Category: Health Maintenance, Nutrition, and Metabolism

  • 1500 Health Maintenance, Nutrition, and Metabolism

Authors

  • Suzuki, Tomo, Kameda Medical Center, Kamogawa, Chiba, Japan
  • Inanaga, Ryohei, Shin-Yurigaoka General Hospital, Kawasaki, Kanagawa, Japan
  • Toida, Tatsunori, Toho Daigaku Iryo Center Ohashi Byoin, Meguro, Tokyo, Japan
  • Sofue, Tadashi, Kagawa Daigaku, Takamatsu, Kagawa Prefecture, Japan
  • Kawarazaki, Hiroo, Teikyo University Hospital Mizonokuchi, Kawasaki, Kanagawa, Japan
  • Shibagaki, Yugo, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
  • Kurita, Noriaki, Tokai Daigaku Igakubu Daigakuin Igaku Kenkyuka, Isehara, Kanagawa, Japan
Background

Patients with chronic kidney disease (CKD) who face kidney replacement therapy (KRT) often experience diminished hope regarding their future, purpose in life, and health. Shared decision-making (SDM) involving multidisciplinary healthcare professionals may support treatment selection, and trust is considered central to effective SDM. However, factors associated with SDM quality remain poorly understood. We therefore investigated associations among trust in the nephrologist who usually followed the patient ("usual nephrologist"), patient hope, and SDM quality.

Methods

We conducted a multicenter cross-sectional study of adults with stage 5 CKD immediately after KRT modality selection at 49 centers in Japan between October 2022 and February 2025. Trust in the usual nephrologist was assessed with the Abbreviated Wake Forest Physician Trust Scale (A-WFPTS), hope with the Health-Related Hope Scale (HR-Hope), and SDM quality with the CollaboRATE scale. General linear models adjusted for age, frailty, depressive symptoms, socioeconomic factors, attendance of the usual nephrologist during KRT decision-making, and duration of the patient–physician relationship.

Results

A total of 462 patients were included. Higher A-WFPTS scores were associated with higher HR-Hope scores (coefficient per 1-point increase, 0.41; 95% CI, 0.29–0.53).
In models excluding HR-Hope, higher A-WFPTS scores were associated with higher SDM scores (0.72; 95% CI, 0.61–0.83). In models excluding trust, higher HR-Hope scores were also associated with higher SDM scores (0.17; 95% CI, 0.06–0.28).
However, when both variables were included, trust in the usual nephrologist remained associated with higher SDM scores (0.73; 95% CI, 0.62–0.84), whereas HR-Hope was no longer significant. Attendance of the usual nephrologist during KRT decision-making was independently associated with higher SDM scores compared with other dedicated KRT physicians (4.60; 95% CI, 1.58–7.62).

Conclusion

Trust in the usual nephrologist may help maintain patient hope and plays a central role in achieving high-quality SDM during KRT selection.

Acknowledgment

This study was supported by JSPS KAKENHI (grant numbers: JP19KT0021, JP21K10314, and JP22K19690). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Funding

  • Government Support – Non-U.S.